³Ô¹ÏÍøÕ¾

Latest

Latest therapeutics News | Page 5

  • Latest therapeutics news stories and updates. What is happening today? All recent therapeutics news and developments. Live coverage and timeline of therapeutics. All you need to know about therapeutics.
Oral delivery possibility for silica-based C’Dots
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study
The Cell and Gene Catalyst call for change in submission to scope of practice review
Alterity Therapeutics raises $4.8 million in new placement
ASX Hopeful Aegros Appoints Ex-MP As Advisory Committee Chair
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
Funding supports research speciality in WA
Antimicrobial Resistance: Silent Pandemic
Alterity Therapeutics announces presentation of new data for ATH434
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Australian-invented drug technology used for treatment of anxiety disorders significantly reduces stress hormone response: Phase 2a clinical trial results
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Professor Dion Stub announced as Heart Foundations new Chair of its Victorian Advisory Board
WHO updates guidelines on treatments for COVID-19
Boosting beta cells to treat Type 2 diabetes
Australia, US scientists team up on African swine fever vaccine
Jessica’s story, ovarian cancer at young age
New centre to develop treatments for aggressive cancers
Opthea announces leadership transition with the appointment of US-based executives
AusBioInvest 2023 connects innovators with investment
Public support needed to advance treatment in deadly brain cancers
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
WA’s innovative healthcare to be showcased on open day
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
AusBioInvest 2023 programme launched
‘We could see it happening before our eyes’: research shows how cancer cells resist chemotherapy
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
$15 million for research to better treat prostate and childhood cancer
$15 million for new cancer fighting research centre
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Targeting unsuspected protein reverses lymphedema
Research reveals how disordered proteins contribute to the properties of the rabies virus
Research brings better understanding of how disordered proteins contribute to the properties of the rabies virus
Breakthrough in understanding immune responses in inflammatory bowel and lung disease
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type…
Starpharma announces the presentation of DEP irinotecan combination data
Improve use of medicines and medical tests with $26 million in grants
HealthTech InnovationAus award finalists announced
Research assistant Michael Hutton publishes review on atherosclerosis research
NIH Center grant bolsters male contraceptive research
New target to beat cancer drug resistance
Tiny fish could be key to develop treatment against MND
Australian-developed drug receives US FDA approval
Ultrathin nanotech promises to help tackle antibiotic resistance
Top Perth blood cancer researcher wins prestigious award
Non-animal models could deliver $1.5B growth

© 2024 - ³Ô¹ÏÍøÕ¾